首页> 外国专利> PERIPHERAL BLOOD TCR MARKER SEQUENCE FOR COLORECTAL CANCER, DETECTION KIT THEREFOR AND APPLICATION THEREOF

PERIPHERAL BLOOD TCR MARKER SEQUENCE FOR COLORECTAL CANCER, DETECTION KIT THEREFOR AND APPLICATION THEREOF

机译:结直肠癌的外周血TCR标记序列,其检测试剂盒及其应用

摘要

Disclosed are a peripheral blood TCR marker for colorectal cancer, a detection kit therefor and an application thereof. The marker comprises at least one of the proteins set forth in the sequence SpecSeq1-100. In the present invention, on the basis of a high-throughput sequencing method, only a small amount of peripheral blood needs to be taken. RNA is extracted, and an immune profile library is established by means of processing samples. Next, a characteristic TCR sequence in the peripheral blood of colorectal cancer is first determined by means of high-throughput sequencing and TCR data analysis, and then test results of a sample to be tested are compared to the characteristic TCR sequence so as to determine whether a patient has colorectal cancer. In the present invention, a huge number of colorectal cancer-specific TCR sequences may be compared at the same time, which has higher specificity and accuracy than detecting one or several markers separately, thereby increasing the diagnosis efficiency.
机译:公开了一种用于结直肠癌的外周血TCR标志物,其检测试剂盒及其应用。标记物包含序列SEMSEQ1-100中阐述的至少一种蛋白质。在本发明中,在高通量测序方法的基础上,仅需要少量的外围血液。提取RNA,通过加工样品建立免疫剖面文库。接下来,首先通过高通量测序和TCR数据分析确定结直肠癌外周血的特征TCR序列,然后将要测试的样品的测试结果与特性TCR序列进行比较,以确定是否患者具有结直肠癌。在本发明中,可以同时比较大量的结肠直肠癌特异性TCR序列,其具有比单独检测一个或多个标记更高的特异性和精度,从而提高了诊断效率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号